ArticleCureus2026
Fetal Adrenal Mass on Ultrasound: A Rare Prenatal Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital neuroblastoma is a rare fetal malignancy arising from neural crest cells, most commonly from the adrenal gland. We report a case of a primigravida in whom a left suprarenal mass was incidentally detected on routine third-trimester ultrasonography at 35 weeks' gestation in an uncomplicated pregnancy, and conservative antenatal management with close fetal surveillance with multidisciplinary care was adopted. The patient delivered a live male neonate at term by cesarean section for failed induction. Postnatal computed tomography demonstrated a solid left adrenal mass with internal calcifications and retroperitoneal extension, without evidence of metastasis. The diagnosis of neuroblastoma was confirmed by ultrasonography-guided fine-needle aspiration cytology. The infant was treated with combination chemotherapy and tolerated the treatment uneventfully and remained well on follow-up. This case highlights the value of antenatal diagnosis, which facilitates early surveillance and management through a multidisciplinary approach, thereby optimizing outcomes in congenital neuroblastoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.